MK-8617,
N-(bis(4-methoxyphenyl)methyl)-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide,
MK-8617,
1187990-87-9,
UNII-39RRC0G27V,
39RRC0G27V,
MK 8617,
N-(bis(4-methoxyphenyl)methyl)-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide,
SCHEMBL3407165,
BCP25371,
EX-A1986,
s8443,
AKOS030622836,
AKOS032960451,
ZINC143933089,
ACN-041446,
N-(bis(4-methoxyphenyl)methyl)-6-oxo-2-(pyridazin-3-yl)-1,6-dihydropyrimidine-5-carboxamide,
AK670649,
DA-14841,
DS-19919,
HY-101023,
CS-0020731,
FT-0710163,
5-Pyrimidinecarboxamide, N-(bis(4-methoxyphenyl)methyl)-1,6-dihydro-6-oxo-2-(3-pyridazinyl)-,
WXLPERVDMILVIF-UHFFFAOYSA-N,
n-[bis(4-methoxyphenyl)methyl]-4-hydroxy-2-pyridazin-3-ylpyrimidine-5-carboxamide,